Angel Kiss

Insurers wary of Obamacare unknowns as they plan for 2015
By Caroline Humer NEW YORK (Reuters) - U.S. health insurers are struggling to set prices for their Obamacare plans in 2015 and decide which regions to return to before the deadlines for submitting those plans to regulators. Some insurers already e...

When Zach met Barack: pitching Obamacare online
By Mark Felsenthal WASHINGTON (Reuters) - President Barack Obama took his quest to sign young people up for health insurance to an edgy comedy website on Tuesday, where he traded insults with host Zach Galifianakis while plugging his signature Oba...

Preschoolers Beat College Kids at Figuring Out Gadgets
TUESDAY, March 11, 2014 (HealthDay News) -- When faced with a strange, new gizmo, preschoolers figured out how it worked more quickly than college students did, a new study shows. The likely reason, according to the researchers, is that very young...

FDA approves electric headband to prevent migraine
WASHINGTON (AP) — The Food and Drug Administration said Tuesday it approved a nerve-stimulating headband as the first medical device to prevent migraine headaches.

Especially for women, hearing loss linked to depression
Higher rates of depression were most common among women and among the middle aged, compared to people over 70, researchers found. A few smaller studies have shown a connection between hearing loss and depression, but they were not based on nation...

Profit-taking drags Wall Street lower
By Rodrigo Campos NEW YORK (Reuters) - U.S. stocks fell on Tuesday, with selling picking up late in the session, as investors cashed in some of the recent market gains, but the S&P 500 finished less than 1 percent away from a record high set last ...

Judge in Colorado theater massacre case appoints new sanity evaluator
By Keith Coffman DENVER (Reuters) - A judge overseeing the Colorado movie theater massacre case appointed an evaluator on Tuesday to conduct a second sanity examination of accused gunman James Holmes after earlier ruling a first evaluation to be ...

Oxigene Inc says drug meets main goal of ovarian cancer trial
(Reuters) - Oxigene Inc said on Tuesday that its experimental drug Zybrestat combined with Roche's big selling cancer drug Avastin significantly slowed progression of recurrent ovarian cancer better than Avastin alone in a midstage clinical tr...

Challenges remain before docs use whole-genome sequencing
Researchers found that sequencing a person's whole genome - all three billion or so DNA nucleotides in the chromosomes - required a significant amount of manpower for a small payoff. One of the study's authors said the cost of sequencing ...

Carnival passengers sue for damages over disrupted 2013 cruise
(This March 10 story's headline and 1st paragraph have been corrected to show passengers are not seeking $5,000 per month for life and corrects 11th paragraph quote to two hours from five hours) By David Quiñones MIAMI (Reuters) - Three pass...